openPR Logo
Press release

Gastroesophageal Reflux Disease (GERD) Therapeutics Market Along With Covid-19 Impact Analysis and Clinical Outlook – 2026 | AstraZeneca, Eisai, GSK

06-08-2020 12:41 PM CET | Health & Medicine

Press release from: Market Insights Reports

Latest Industry Research Report On global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Research Report 2020 in-depth analysis of the market state and also the competitive landscape globally.

The Gastroesophageal Reflux Disease (GERD) Therapeutics market report provides information regarding market size, share, trends, growth, cost structure, global market competition landscape, market drivers, challenges and opportunity, capacity, revenue and forecast 2026. This report also includes the overall and comprehensive study of the Gastroesophageal Reflux Disease (GERD) Therapeutics market with all its aspects influencing the growth of the market. This report is exhaustive quantitative analyses of the Gastroesophageal Reflux Disease (GERD) Therapeutics industry and provides data for making strategies to increase market growth and effectiveness.

This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Click the link to get a Sample Copy of the Report before purchase:

https://www.marketinsightsreports.com/reports/04242003258/global-gastroesophageal-reflux-disease-gerd-therapeutics-market-size-status-and-forecast-2020-2026/inquiry?Mode=56&Source=openpr

The Following Top Key Players in the Gastroesophageal Reflux Disease (GERD) Therapeutics Market:

AstraZeneca
Eisai
GSK
Takeda
Johnson & Johnson, Vivonics, and other.

Industrial News:

Additional Dosage and Administration of Proton Pump Inhibitor Pariet® 5 mg Tablets, 10 mg Tablets Approved in Japan for Maintenance Therapy of Proton Pump Inhibitor Resistant Reflux Esophagitis

September 22, 2017

Eisai Co., Ltd.
EA Pharma Co., Ltd.

Eisai Co., Ltd. (Headquarters, Tokyo; CEO, Haruo Naito; “Eisai”) and Eisai's subsidiary for gastrointestinal disease area EA Pharma Co., Ltd. (Headquarters, Tokyo; President & CEO, Yuji Matsue; “EA Pharma”) announced today that Eisai has obtained the approval of additional dosage and administration in Japan of the proton pump inhibitor Pariet® 5 mg Tablets and 10 mg Tablets (generic name: rabeprazole sodium) to administer 10 mg of rabeprazole sodium per dose twice-daily for the maintenance therapy of proton pump inhibitor-resistant reflux esophagitis (reflux esophagitis in which it is difficult to achieve satisfactory therapeutic effects by existing treatment with once-daily dosing of proton pump inhibitors). In Japan, Eisai is the marketing and manufacturing authorization holder for Pariet, while EA Pharma is responsible for distribution.

This report segments the Gastroesophageal Reflux Disease (GERD) Therapeutics market on the basis of Types are:

Antacids
Pro-kinetic agents
H2 Receptor Blockers
Proton Pump Inhibitors (PPIs)
Other

On the basis of Application, the Gastroesophageal Reflux Disease (GERD) Therapeutics market is segmented into:

Heartburn
Acid reflux disorders
Other

Inquiry for discount (Exclusive offer: get flat 20% discount):

https://www.marketinsightsreports.com/reports/04242003258/global-gastroesophageal-reflux-disease-gerd-therapeutics-market-size-status-and-forecast-2020-2026/discount?Mode=56&Source=openpr

Regional outlook: The regions covered in the reports of the Gastroesophageal Reflux Disease (GERD) Therapeutics market are

North America (United States, Canada, and Mexico)
Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Malaysia, Philippines, Thailand, Vietnam)
Europe (Germany, France, UK, Italy, Russia, Rest of Europe)
Central & South America (Brazil, Rest of South America)
Middle East & Africa (GCC Countries, Turkey, Egypt, South Africa, Other)

Highlights the following key factors:

- Business description: – A detailed description of the company’s operations and business divisions.
- Corporate strategy: – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis: – A detailed analysis of the company’s strengths, weaknesses, opportunities, and threats.
- Company history: – Progression of key events associated with the company.
- Major products and services: – A list of major products, services, and brands of the company.
- Key competitors: – A list of key competitors to the company.
- Important locations and subsidiaries: – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years: – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

The report has 150 tables and figures browse the report description and TOC:

https://www.marketinsightsreports.com/reports/04242003258/global-gastroesophageal-reflux-disease-gerd-therapeutics-market-size-status-and-forecast-2020-2026?Mode=56&Source=openpr

We also offer customization on reports based on specific client requirement:

- Free country-level analysis for any 5 countries of your choice.
- Free Competitive analysis of any 5 key market players.
- Free 40 analyst hours to cover any other data points.

Scope of the report:

The report evaluates the growth rate and the Market value based on Market dynamics, growth inducing factors. The complete knowledge is based on the latest industry news, opportunities and trends. The report contains a comprehensive Market analysis and vendor landscape in addition to a SWOT analysis of the key vendors.

Note - All the reports that we list have been tracking the impact of COVID-19. Both upstream and downstream of the entire supplychain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

You Can Browse Following Related Reports

Global Gastroesophageal Reflux Disease Treatment Device Market Research Report 2020
https://www.marketinsightsreports.com/reports/01271796367/global-gastroesophageal-reflux-disease-treatment-device-market-research-report-2020?Mode=56

COVID-19 Impact On Gastroesophageal PH Meter Market, Global Research Reports 2020-2021
https://www.marketinsightsreports.com/reports/05272046596/covid-19-impact-on-gastroesophageal-ph-meter-market-global-research-reports-2020-2021?Mode=56

COVID-19 Impact On Gastroesophageal PH Meter Market, Global Research Reports 2020-2021
https://www.marketinsightsreports.com/reports/04282010584/fgfrpositive-gastroesophageal-cancer-pipeline-insight-2020?Mode=56

Contact Us:

Irfan Tamboli (Head of Sales) - Market Insights Reports
sales@marketinsightsreports.com | irfan@marketinsightsreports.com
Phone: - + 1704 266 3234 | +91-750-707-8687

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastroesophageal Reflux Disease (GERD) Therapeutics Market Along With Covid-19 Impact Analysis and Clinical Outlook – 2026 | AstraZeneca, Eisai, GSK here

News-ID: 2069373 • Views:

More Releases from Market Insights Reports

Cold Chain Monitoring Market May See a Big Move | BlueAir, Denso, Eureka Forbes, Honeywell
Cold Chain Monitoring Market May See a Big Move | BlueAir, Denso, Eureka Forbes, …
Market Insights Reports published a new research publication on "Cold Chain Monitoring Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Cold Chain Monitoring market was mainly driven by the increasing R&D spending across the world. Some of the key players
Outbound Logistics Market Next Big Thing | Major Giants- Draexlmaier, Faurecia, Grupo Antolin
Outbound Logistics Market Next Big Thing | Major Giants- Draexlmaier, Faurecia, …
Market Insights Reports published a new research publication on "Outbound Logistics Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Outbound Logistics market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in
Veterinary Telemedicine Market May See a Big Move | Nestle, Deuerer, The J.M. Smucker
Veterinary Telemedicine Market May See a Big Move | Nestle, Deuerer, The J.M. Sm …
Market Insights Reports published a new research publication on "Veterinary Telemedicine Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Veterinary Telemedicine market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in
Precision Planting Market is Set to Fly High in Years to Come
Precision Planting Market is Set to Fly High in Years to Come
Market Insights Reports published a new research publication on "Precision Planting Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Precision Planting market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in

All 5 Releases


More Releases for Gastroesophageal

Gastroesophageal Reflux Disease Therapeutics Market Heartburn Relief on the Rise …
Gastroesophageal Reflux Disease Therapeutics Market to reach over USD 6.06 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Gastroesophageal Reflux Disease Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Antacids, H2 Receptor Blockers, Proton Pump Inhibitors (PPIs), and Pro-kinetic agents)- Market Outlook And Industry Analysis 2031" The global Gastroesophageal Reflux Disease
Gastroesophageal Reflux Disease Device Market Size 2024 to 2031.
Market Overview and Report Coverage Gastroesophageal Reflux Disease (GERD) devices are medical devices used to treat GERD, a chronic disease characterized by the reflux of stomach acid into the esophagus. These devices include sphincter augmentation devices, magnetic sphincter augmentation devices, and radiofrequency ablation devices, among others. They are designed to help alleviate symptoms of GERD and improve the quality of life for patients. The Gastroesophageal Reflux Disease Device Market is
Gastroesophageal Reflux Disease Therapeutics Market: Trends and Projections -203 …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033 The Business Research Company presents an extensive market research report on the Gastroesophageal Reflux Disease Therapeutics Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments. Furthermore, the report highlights on emerging trends, significant drivers, challenges,
Gastroesophageal Junction Adenocarcinoma Therapeutics Market - Revolutionizing C …
Newark, New Castle, USA: The "Gastroesophageal Junction Adenocarcinoma Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Gastroesophageal Junction Adenocarcinoma Therapeutics Market: https://www.growthplusreports.com/report/gastroesophageal-junction-adenocarcinoma-therapeutics-market/8809 This latest report researches the
Gastroesophageal Reflux Disease Therapeutics Market
As per the research conducted by GME, the Global Gastroesophageal Reflux Disease Therapeutics Market will grow with a CAGR value of 4.1%. During the forecasted timeframe, the gastroesophageal reflux disease market is likely to be sustained by a rise in the number of patients being treated for gastroesophageal reflux disease and long-term anti-reflux conservation therapy. Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC
Gastroesophageal Reflux Disease (GERD) Treatment Devices Market – Latest Devel …
Gastroesophageal Reflux Disease (GERD) Treatment Devices Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Gastroesophageal Reflux Disease (GERD) Treatment Devices market research report is a professional and in-depth study on the current state of Gastroesophageal Reflux Disease (GERD) Treatment Devices Industry. The Gastroesophageal Reflux